Long non-coding ribonucleic acid W5 inhibits progression and predicts favorable prognosis in hepatocellular carcinoma

Table 2 Cox proportional hazards model analysis of clinicopathologic features related to overall survival in terms of long non-coding ribonucleic acid W5 expression in hepatocellular carcinoma patients

Variables	Univariate analysis			Multivariate analysis
	P value	HR	95%CI	P value	HR	95%CI
Expression (high/low)	0.041a	1.672	1.032-2.159	0.027a	1.285	0.867-2.155
Pathologic-Stage (I + II/III + IV)	0.001a	2.584	1.934-4.162	0.159	2.436	0.715-7.667
Pathologic-T (T1 + T2/T3 + T4)	0.004a	4.068	1.573-8.869	0.014a	10.638	2.314-57.649
Pathologic-M (M0/M1)	0.007a	5.294	3.195-7.657	0.005a	3.082	1.726-5.342
Pathologic-N (N0/N1 + N2 + N3)	0.002a	2.413	1.519-3.969	0.246	0.719	0.312-1.911
Age (< 60/ ≥ 60 yrs)	0.342	1.402	0.914-2.357
Gender (female/male)	0.258	1.324	0.849-1.905

^aP < 0.05. HR: Hazard ratio; CI: Confidence interval.